Skip to main content
UCB logo

UCB — Investor Relations & Filings

Ticker · UCB ISIN · BE0003739530 LEI · 2138008J191VLSGY5A09 BR Manufacturing
Filings indexed 2,023 across all filing types
Latest filing 2014-02-21 Proxy Solicitation & In…
Country BE Belgium
Listing BR UCB

UCB is a global biopharmaceutical company that focuses on creating solutions for people living with severe diseases, primarily in the fields of neurology and immunology. The company's core activities include the research, development, and commercialization of pharmaceutical and biotechnology products. Guided by a patient-centric and science-driven approach, UCB is committed to innovation and sustainability. Through its UCB Ventures arm, it invests in pioneering technologies and companies with the potential to transform patient care. The company also offers personalized support services to patients and healthcare professionals during their treatment journey with a UCB medicine.

Recent filings

Filing Released Lang Actions
Volmacht Buitengewone Algemene Vergadering 24 maart 2014.pdf
Proxy Solicitation & Information Statement Classification · 98% confidence The document is titled "VOLMACHT VOOR DE BUITENGEWONE ALGEMENE VERGADERING VAN AANDEELHOUDERS VAN 24 MAART 2014 OM 9:00 UUR" (Proxy for the Extraordinary General Meeting of Shareholders of March 24, 2014). It explicitly details the process for appointing a proxy holder, voting instructions, and lists several proposed resolutions (agendapunten) to be voted upon at this meeting, including capital authorization and share repurchase renewal. This content is characteristic of materials used to solicit shareholder votes for a general meeting, which aligns directly with the definition of Proxy Solicitation & Information Statement (PSI). Although it relates to an AGM/EGM, the core function is soliciting proxy votes, making PSI more specific than AGM-R.
2014-02-21 Dutch
Agenda Extraordinary General Meeting 24 March 2014.pdf
AGM Information Classification · 98% confidence The document explicitly states it is for an 'EXTRAORDINARY GENERAL MEETING OF SHAREHOLDERS' held on '24 March 2014' and details the 'AGENDA' items, which include proposals for amending the Articles of Association regarding authorized capital (Item 2) and the acquisition/renewal of authorization for the purchase of own shares (Item 3). These are core topics discussed and voted upon during a General Meeting. Since the document contains the agenda and proposed resolutions for the meeting itself, it aligns best with the 'AGM Information' category, which covers presentations and materials shared during the Annual General Meeting (AGM) or, by extension, Extraordinary General Meetings (EGM).
2014-02-21 English
Rapport spécial du Conseil aux actionnaires.pdf
Capital/Financing Update Classification · 98% confidence The document is titled "RAPPORT SPÉCIAL DU CONSEIL D'ADMINISTRATION AUX ACTIONNAIRES concernant l'usage du capital autorisé" (Special Report of the Board of Directors to Shareholders concerning the use of authorized capital). This document explicitly discusses proposals to grant the Board of Directors authorization to increase the share capital under the 'authorized capital' framework, detailing the limits (5% or 10% of capital) and conditions for its use, and proposing amendments to Article 6 of the company's statutes. This subject matter—proposals related to capital structure changes requiring shareholder approval, often presented ahead of a general meeting—is highly indicative of materials related to corporate governance and capital financing decisions. Since it is a detailed report/proposal regarding capital structure changes and authorization for future capital increases, it fits best under 'Capital/Financing Update' (CAP). It is not a standard Annual Report (10-K), an Earnings Release (ER), or a simple Dividend Notice (DIV). It is a specific report detailing a proposed capital structure change.
2014-02-21 French
Agenda Buitengewone Algemene Vergadering 24 maart 2014.pdf
AGM Information Classification · 98% confidence The document explicitly states it concerns a "BUITENGEWONE ALGEMENE VERGADERING VAN AANDEELHOUDERS" (Extraordinary General Meeting of Shareholders) held on March 24, 2014. The content details the agenda items, which include proposals for capital authorization renewal (Item 2), renewal of authorization for share repurchase (Item 3), and amendments to the company's articles of association (Items 2, 4, 5). These materials—the agenda and proposed resolutions for a shareholder meeting—are characteristic of materials presented or distributed in connection with an Annual General Meeting (AGM) or Extraordinary General Meeting (EGM). Since the definition for AGM-R covers 'Presentations and materials shared during the Annual General Meeting (AGM)', and this is an EGM agenda/proposal set, AGM-R is the most appropriate classification, as EGM materials often fall under this umbrella when a specific EGM code is not provided, or they are closely related to the governance aspects covered by AGM materials. It is not a DEF 14A (Remuneration) or DVA (Voting Results), but the meeting materials themselves.
2014-02-21 Dutch
Convening notice Extraordinary General Meeting 24 March 2014.pdf
AGM Information Classification · 99% confidence The document is explicitly titled 'CONVENING NOTICE TO ATTEND THE EXTRAORDINARY GENERAL MEETING OF SHAREHOLDERS'. It details the date, time, location, and the specific agenda items (proposals regarding authorized capital, amendment of Articles of Association, and acquisition of own shares) for a shareholder meeting. This content directly relates to the formal procedures and materials for an Annual General Meeting (AGM) or Extraordinary General Meeting (EGM). The most appropriate classification among the provided options is AGM-R (AGM Information), as it is the convening notice for such a meeting.
2014-02-21 English
Convocation Assemblée Générale Extraordinaire 24 mars 2014.pdf
AGM Information Classification · 100% confidence The document is explicitly titled "CONVOCATION À ASSISTER À L'ASSEMBLÉE GÉNÉRALE EXTRAORDINAIRE DES ACTIONNAIRES" (Notice to attend the Extraordinary General Meeting of Shareholders). It details the date, time, location, and the specific agenda items (Ordre du Jour) for the meeting, which include proposals regarding authorized capital, statutory amendments, and share buybacks. This content directly relates to the formal gathering of shareholders and the materials presented for voting, fitting the definition of AGM Information.
2014-02-21 French

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.